Kat,
We have been over this ground before. Your
Kat,
We have been over this ground before. Your experience, while admirable, has not been with public companies and I believe your experience has limited applicability. From where I stand, without Bret, we would have all been sold down the river in 2007 when prior management was looking to spin off all relevant assets to a new shell company. Bret stepped up and has been leading this company at a great personal sacrifice. Is it a high risk venture? Yes. Do I wish the traded value was higher? Yes. Are there substantial forces aligned against the company, some of whom are involved in illicit dealings? I believe so. There are paid bashers on multple boards, the company knows the IP addresses of them, and then there are the plain wackos who have personal vendettas against other shareholders. Else..what would an interesting day be in nano-board-land? Eh?
I just haven't seen you add anything substantive to the discussion during the 5 years during which I've been a shareholder. I don't see how your whining is helpful. We will have to agree to disagree. I, for one, would not support your attempt to replace Bret nor the BOD. Nor, I suspect, would the majority of longs.
Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Top 5 Most Recently Viewed Articles
Exploring the Magnetic Force Microscope Market The magnetic force microscope (MFM) market is on a path of significant expansion, with predictions indicating growth from approximately USD 356 million to over USD 798 million over the next decade. This upward trend highlights a strong compound annual growth rate (CAGR) of 8.4%. The MFM is a vital tool in both industrial and...
Continue Reading
Brewing Trouble: Legal Storm for Black Rock Coffee Amid the aroma of freshly ground beans, Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) finds itself in a bitter brew of legal troubles. The steaming hot news is a securities class action lawsuit challenging the company's disclosures from its IPO. Investors who bought into the hype at $20 a share are now left with a lukewarm...
Continue Reading
Modaxo Expands Its Global Reach with New Acquisition Modaxo Inc. is a forward-thinking organization dedicated to enhancing the movement of people worldwide. Recently, the company has made strides in this mission by acquiring SISCOG - Sistemas Cognitivos, S.A., a well-respected provider of planning and scheduling technology solutions in the rail sector. This acquisition...
Continue Reading
Greater Washington Oral and Maxillofacial Surgery Opens New Office Greater Washington Oral and Maxillofacial Surgery is excited to announce the launch of its newest office in Stafford, Virginia. This strategic expansion underscores the practice's commitment to providing advanced oral surgical care and enhancing patient access in the region. A Commitment to Community and...
Continue Reading
Goldman Sachs Downgrades Pluxee France In a significant market shift, Goldman Sachs has announced a downgrade for Pluxee France SA (PLX: FP), moving its rating from Neutral to Sell. This decision demonstrates the firm's critical analysis of Pluxee's stock performance and its overall market position. Revised Price Target Alongside the downgrade, Goldman Sachs has adjusted...
Continue Reading